BIO-key International Inc (NAS:BKYI)
$ 3.15 -0.030 (-0.97%) Market Cap: 4.52 Mil Enterprise Value: 3.89 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 42/100

Q1 2025 BIO-Key International Inc Earnings Call Transcript

May 16, 2025 / 02:00PM GMT
Release Date Price: $8.33 (-1.88%)

Key Points

Positve
  • BIO-key International Inc (BKYI) reported a 10% increase in Q1 2025 revenue to $1.6 million compared to Q4 2024, driven by high-margin Baoki-branded products in the EMEA region.
  • The company achieved a healthy gross profit margin of 83% due to its high-margin software as a service model.
  • BIO-key's cash position increased substantially to over $3 million, reflecting proceeds from warrant exercises.
  • The company reduced its SG&A expenses by 23% year over year, demonstrating effective cost management.
  • BIO-key is seeing solid traction for its identity-bound biometric solutions in key verticals such as defense and financial services, which require high levels of security and privacy.
Negative
  • Year-over-year revenue comparison was negatively impacted by a $1.2 million revenue from a two-year contract in Q1 last year, leading to a decrease in total revenue.
  • The company's Q1 2025 net loss increased to approximately $737,000, up from $573,000 in the prior year period.
  • Gross margin declined slightly to 82.6% in Q1 2025 from 86.3% in Q1 2024, due to an increase in low-margin hardware as a percentage of revenue.
  • BIO-key's financial performance is expected to fluctuate quarter to quarter due to the variable timing of large customer orders and renewals.
  • The transition away from swivel secure license solutions has created some revenue headwinds in the latter half of 2024 and 2025.
Operator

Good morning, everyone. Thank you for standing by and welcome to BIO-key International's first quarter 2025 conference call. (Operator Instructions) As a reminder, this conference is being recorded today, Friday, May 16, 2025.

I will now turn the call over to Bill Jones, Investor Relations. You may proceed, sir.

Bill Jones
BIO-key International Inc - Investor Relations

Thank you, Rocco. Hosting today are BIO-key's Chairman and CEO, Mike DePasquale and Chief Financial Officer Cecilia Welch. As a reminder, today's conference call on webcast and answers to investor questions include forward-looking statements which are subject to risks and uncertainties that may cause actual results to differ materially from current expectations. Words including anticipate, believe, estimate, expect, plan. And project or similar words generally identify and express such forward-looking statements.

These forward-looking statements are made based on beliefs, assumptions, and information currently available to management today pursuant to the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot